BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25776025)

  • 1. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
    Zenali MJ; Weissferdt A; Solis LM; Ali S; Tang X; Mehran RJ; Wistuba II; Moran CA; Kalhor N
    Hum Pathol; 2015 Jun; 46(6):836-42. PubMed ID: 25776025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
    Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
    Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
    Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological significance of ALK rearrangements and KRAS and EGFR mutations in primary pulmonary mucinous adenocarcinoma.
    Qu Y; Che N; Zhao D; Zhang C; Su D; Zhou L; Zhang L; Wang C; Zhang H; Wei L
    Tumour Biol; 2015 Aug; 36(8):6417-24. PubMed ID: 25813151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomorphological features of ALK-positive lung adenocarcinomas: psammoma bodies and signet ring cells.
    Pareja F; Crapanzano JP; Mansukhani MM; Bulman WA; Saqi A
    Cancer Cytopathol; 2015 Mar; 123(3):162-70. PubMed ID: 25557162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features of lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements].
    Dong Y; Zhou L; Wang J; Cai Y; Mu J; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):436-40. PubMed ID: 26463147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic analysis of 10 cases of pulmonary colloid adenocarcinoma and prognostic implication of invasive micropapillary component.
    Cha YJ; Shim HS; Han J; Choi YS
    Pathol Res Pract; 2018 Dec; 214(12):2093-2098. PubMed ID: 30377026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
    Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
    [No Abstract]   [Full Text] [Related]  

  • 12. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
    Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665
    [No Abstract]   [Full Text] [Related]  

  • 14. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
    Genova SN; Belovezhdov VT; Bichev SN; Danev VH
    Folia Med (Plovdiv); 2017 Jun; 59(2):174-182. PubMed ID: 28704186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status.
    Kim H; Yang JM; Jin Y; Jheon S; Kim K; Lee CT; Chung JH; Paik JH
    Oncotarget; 2017 Jan; 8(5):8484-8498. PubMed ID: 28035073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
    Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
    J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
    Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
    Qu Y; Zhao D; Mu J; Che N; Zhang C; Liu Z; Su D; Zhou L; Zhang H; Wei L
    Tumour Biol; 2016 Jan; 37(1):887-96. PubMed ID: 26254613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
    Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
    Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.